|KOMISJA NADZORU FINANSOWEGO|
|Raport bieżący nr||8||/||2020|
|Skrócona nazwa emitenta|
|The Update on The Partnership with RedOne Medical|
|Art. 17 ust. 1 MAR - informacje poufne.|
| The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company”, “the Issuer”), today
provided an update on its partnership with RedOne Medical, a leading medical device distributor and wholesaler serving the Department of Veterans Affairs (VA) medical centers and the Department of Defense (DoD) hospitals, to distribute the CompuFlo Epidural System. As previously announced on December 13, 2019, Milestone Medical announced that it was partnering with RedOne Medical. The Company fully intends to move forward with this relationship; however, the formal initiation of the partnership has been delayed due to specific government requirements with respect to components originated from, but purchased outside, the People’s Republic of China. The Board of Directors of the Issuer expects to be in a position to comply with such requirements in the near future.
Although the rollout of our CompuFlo Epidural System with RedOne was delayed due to factors outside the control of the Issuer, The Board of Directors of the Company remains excited about the collaboration and opportunity to deploy the CompuFlo Epidural System within Department of Veterans Affairs medical centers and Department of Defense hospitals, both of which represent a significant market opportunity for the Company. The Board of Directors of the Issuer looks forward to providing further updates as developments unfold.
|MESSAGE (ENGLISH VERSION)|
|PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ|
|Data||Imię i Nazwisko||Stanowisko/Funkcja||Podpis|
|2020-02-25||Joseph D'Agostino||Chief Financial Officer||Joseph D'Agostino|
Źródło: GPW - komunikaty spółek (ESPI)